• 1. A new NBS/oxone promoted one pot cascade synthesis of 2-aminobenzimidazoles/2-aminobenzoxazoles: a facile approach
  Ujla Daswani,Nitin Dubey,Pratibha Sharma,Ashok Kumar New J. Chem. 2016 40 8093
• 2. A practically simple, catalyst free and scalable synthesis of N-substituted ureas in water
  Lata Tiwari,Varun Kumar,Bhuvesh Kumar,Dinesh Mahajan RSC Adv. 2018 8 21585
• 3. Phases of membrane polar lipids in aqueous systems
  P. J. Quinn Nat. Prod. Rep. 1984 1 513

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives N-phenylureas
• Solvents and Organic Chemicals Organic Compounds

Professional Introduction to 4-Bromophenylurea (CAS No. 1967-25-5)

4-Bromophenylurea, with the chemical formula C?H?BrN?O and CAS number 1967-25-5, is a significant compound in the field of organic chemistry and pharmaceutical research. This heterocyclic compound features a bromine substituent on a phenyl ring bonded to a urea group, making it a versatile intermediate in the synthesis of various biologically active molecules. The unique structural properties of 4-bromophenylurea have garnered considerable attention from researchers due to its potential applications in drug development and material science.

The< strong>4-bromophenylurea molecule exhibits a distinct electronic distribution due to the presence of the bromine atom, which is an electron-withdrawing group. This characteristic enhances its reactivity in nucleophilic substitution reactions, making it a valuable building block for constructing more complex molecular architectures. In recent years, the pharmaceutical industry has shown increasing interest in halogenated ureas as pharmacophores, owing to their ability to modulate biological pathways effectively.

Recent studies have highlighted the< strong>4-bromophenylurea as a key intermediate in the synthesis of kinase inhibitors, which are crucial in treating various cancers and inflammatory diseases. For instance, modifications of the< strong>4-bromophenylurea scaffold have led to the development of novel compounds that exhibit potent inhibitory activity against tyrosine kinases. These findings underscore the importance of< strong>4-bromophenylurea in medicinal chemistry and its potential to contribute to next-generation therapeutics.

In addition to its pharmaceutical applications, 4-bromophenylurea has been explored in materials science for its role in synthesizing organic semiconductors and liquid crystals. The bromine atom's ability to participate in cross-coupling reactions, such as Suzuki and Heck couplings, makes< strong>4-bromophenylurea an excellent precursor for creating conjugated polymers with desirable optoelectronic properties. These polymers are widely used in organic light-emitting diodes (OLEDs) and photovoltaic devices, contributing to advancements in sustainable energy technologies.

The synthesis of< strong>4-bromophenylurea typically involves the reaction of phenyl isocyanate with bromobenzene under controlled conditions. This process requires careful optimization to ensure high yield and purity, which are critical for subsequent applications. Advances in synthetic methodologies have enabled more efficient production techniques, including catalytic processes that minimize waste and energy consumption. Such innovations align with global efforts to promote green chemistry principles.

In academic research, 4-bromophenylurea has been utilized as a model compound for studying molecular interactions and enzyme mechanisms. Its ability to act as a substrate or inhibitor for various enzymes has provided valuable insights into metabolic pathways and disease mechanisms. For example, studies on urease enzymes have demonstrated how< strong>4-bromophenylurea can serve as a competitive inhibitor, offering potential therapeutic benefits in managing enzymatic disorders.

The< strong>CAS No. 1967-25-5 designation ensures that researchers can reliably identify and source this compound for their experiments. Regulatory agencies recognize this number as a unique identifier, facilitating compliance with safety and quality standards across different jurisdictions. This standardized classification is essential for maintaining consistency in scientific literature and industrial applications.

The versatility of< strong>4-bromophenylurea extends beyond its direct use as an intermediate; it also serves as a starting material for derivatives with tailored properties. Functional groups such as amines or alcohols can be introduced through subsequent reactions, expanding the chemical space available for drug discovery programs. Such flexibility makes< strong>CAS No. 1967-25-5-labeled compounds indispensable tools for synthetic chemists.

In conclusion, 4-Bromophenylurea (CAS No.< strong>1967-25-5) represents a cornerstone compound in modern chemistry, with far-reaching implications in pharmaceuticals and materials science. Its unique structural features and reactivity profile continue to inspire innovative research across multiple disciplines. As scientific understanding evolves, the applications of this remarkable compound are expected to grow even further, reinforcing its significance in advancing both health care and technological innovation.

• 13114-90-4((2-Bromophenyl)urea)
• 93740-30-8(Urea, N-(4-bromophenyl)-N,N'-dimethyl-)
• 3408-97-7(1-(4-bromophenyl)-3,3-dimethylurea)
• 2989-98-2(3-Bromophenylurea)
• 39513-26-3(5-bromo-2,3-dihydro-1H-1,3-benzodiazol-2-one)
• 105946-57-4(1,3-bis(3-bromophenyl)urea)
• 2617-78-9(N-(4-bromophenyl)formamide)
• 175278-34-9(N,N'-Di-(2-bromophenyl)urea)
• 20680-07-3(Urea,N-(4-bromophenyl)-N'-methyl-)
• 20940-43-6(Urea, N'-(3-bromophenyl)-N,N-dimethyl-)